Top Industry Leaders in the Peptic Ulcer Drugs Market
Latest Peptic Ulcer Drugs Companies Updates:
Cadila Healthcare Ltd. received USFDA nod for their ulcer treatment injection, Esomeprazole Sodium, expanding their product portfolio and market reach.
Takeda Pharmaceutical Company Limited launched a novel formulation of lansoprazole for oral suspension, catering to patients with swallowing difficulties.
Daewoong Pharmaceutical Co., Ltd. unveiled a new H. pylori eradication kit combining their clarithromycin-based antibiotic with omeprazole, aiming for improved treatment success rates.
Pfizer Inc. announced plans to expand their OTC portfolio by acquiring a leading brand of antacids, strengthening their presence in the market.
Abbott Laboratories partnered with a research institute to develop a novel diagnostic test for H. pylori that integrates with their existing Point-of-Care platform, aiming for rapid and accessible diagnosis.
List of Peptic Ulcer Drugs Key companies in the market:
-
Novartis AG
-
Daiichi Sankyo Company Limited
-
Acetelion Ltd, Boehringer Ingelheim
-
Sanofi S.A.
-
Astra Zeneca plc
-
Ranbaxy Laboratories Limited, Inc.
-
Takeda Pharmaceuticals Company Limited
-
Pfizer Inc. Helicure AB